Preclinical evaluation of immunomodulatory effects of aurora kinase inhibition in HPV plus cancers

被引：1
|
作者：
Sinha, Pragya
Ghosh, Soma
Johnson, Faye M.
Sastry, Jagannadha K.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5021
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Novel combination of TRIP13 and Aurora kinase A inhibition demonstrated extensive DNA damage and immunogenic cell death in RB-deficient cancers
    Ghosh, Soma
    Mazumdar, Tuhina
    Yapindi, Lacin
    Sinha, Pragya
    Sastry, Jagannadha
    Johnson, Faye M.
    CANCER RESEARCH, 2023, 83 (07)
  • [32] IMMUNOMODULATORY EFFECTS OF THERAPEUTIC GOLD COMPOUNDS - INHIBITION OF PROTEIN-KINASE-C ACTIVITY OF HUMAN T-CELLS
    HASHIMOTO, K
    MATSUBARA, T
    HIROHATA, K
    LIPSKY, PE
    FASEB JOURNAL, 1992, 6 (04): : A1304 - A1304
  • [33] Preclinical evaluation of the effects of a novel antisense compound targeting C-raf kinase in mice and monkeys
    Monteith, DK
    Geary, RS
    Leeds, JM
    Johnston, J
    Monia, BP
    Levin, AA
    TOXICOLOGICAL SCIENCES, 1998, 46 (02) : 365 - 375
  • [34] Preclinical Evaluation of AMG 900, a Novel Potent and Highly Selective Pan-Aurora Kinase Inhibitor with Activity in Taxane-Resistant Tumor Cell Lines
    Payton, Marc
    Bush, Tammy L.
    Chung, Grace
    Ziegler, Beth
    Eden, Patrick
    McElroy, Patricia
    Ross, Sandra
    Cee, Victor J.
    Deak, Holly L.
    Hodous, Brian L.
    Nguyen, Hanh Nho
    Olivieri, Philip R.
    Romero, Karina
    Schenkel, Laurie B.
    Bak, Annette
    Stanton, Mary
    Dussault, Isabelle
    Patel, Vinod F.
    Geuns-Meyer, Stephanie
    Radinsky, Robert
    Kendall, Richard L.
    CANCER RESEARCH, 2010, 70 (23) : 9846 - 9854
  • [35] Evaluation of the effects of combined chemical inhibition of PARP and BET proteins in preclinical models of urothelial bladder cancer
    Maffuid, Kaitlyn A.
    Torrice, Chad D.
    Hardy, Brian
    Murphy, William A.
    James, Lindsey, I
    Kim, William Y.
    Frye, Stephen, V
    Pearce, Kenneth J.
    Crona, Daniel J.
    CANCER RESEARCH, 2020, 80 (16)
  • [36] Cooperative effects of Janus and Aurora kinase inhibition by CEP701 in cells expressing Jak2V617F
    Gaebler, Karoline
    Rolvering, Catherine
    Kaczor, Jakub
    Eulenfeld, Rene
    Mendez, Sergio Alvarez
    Berchem, Guy
    Palissot, Valerie
    Behrmann, Iris
    Haan, Claude
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2013, 17 (02) : 265 - 276
  • [37] Blockade of beta-catenin pathway combined with Aurora kinase activity inhibition enhances antitumor effects in adrenocortical cancer cells.
    Maria, Andrea G.
    Borges, Kleiton S.
    Lira, Regia C.
    Thome, Carolina H.
    Berthon, Annabel
    Drougat, Ludivine
    Faucz, Fabio R.
    Faca, Vitor M.
    Tone, Luiz G.
    Stratakis, Constantine A.
    CANCER RESEARCH, 2021, 81 (13)
  • [38] Bruton's Tyrosine Kinase Inhibitors: Approaches to Potent and Selective Inhibition, Preclinical and Clinical Evaluation for Inflammatory Diseases and B Cell Malignancies
    Lou, Yan
    Owens, Timothy D.
    Kuglstatter, Andreas
    Kondru, Rama K.
    Goldstein, David M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (10) : 4539 - 4550
  • [39] Effects of PYCR1 on prognosis and immunotherapy plus tyrosine kinase inhibition responsiveness in metastatic renal cell carcinoma patients
    Xu, Xianglai
    Wang, Ying
    Hu, Xinyu
    Zhu, Yanjun
    Wang, Jiajun
    Guo, Jianming
    NEOPLASIA, 2023, 43
  • [40] Preclinical evaluation of the Aurora kinase inhibitors AMG 900, AZD1152-HQPA, and MK-5108 on SW-872 and 93T449 human liposarcoma cells
    Noronha, Sandhya
    Alt, Lauren A. C.
    Scimeca, Taylor E.
    Zarou, Omran
    Obrzut, Justyna
    Zanotti, Brian
    Hayward, Elizabeth A.
    Pillai, Akhil
    Mathur, Shubha
    Rojas, Joseph
    Salamah, Ribhi
    Chandar, Nalini
    Fay, Michael J.
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2018, 54 (01) : 71 - 84
12345